Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids

eLife

Volumn 5, Issue JUNE2016, 2016, Pages

  Li, Yen Li ^a   Chandrasekaran, Viswanathan ^a   Carter, Stephen D ^b   Woodward, Cora L ^b   Christensen, Devin E ^a   Dryden, Kelly A ^c   Pornillos, Owen ^c   Yeager, Mark ^c,d   Ganser Pornillos, Barbie K ^c   Jensen, Grant J ^b   Sundquist, Wesley I ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; RECOMBINANT TRIPARTITE MOTIF PROTEIN 5; RECOMBINANT PROTEIN; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; CARRIER PROTEIN; HYBRID PROTEIN;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DEEP ETCH ELECTRON MICROSCOPY; DISULFIDE BOND; ELECTRON MICROSCOPY; ELECTRON TOMOGRAPHY; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMATE; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; TRANSMISSION ELECTRON MICROSCOPY; VIRION; VIRUS CAPSID; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DIMERIZATION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

ANIMALS; CAPSID; CARRIER PROTEINS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; GENE EXPRESSION REGULATION; HEK293 CELLS; HIV-1; HUMANS; PRIMATES; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS;

EID: 84978880224     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.16269     Document Type: Article

References (140)

1. Agulleiro JI, Fernandez JJ. 2011. Fast tomographic reconstruction on multicore computers. Bioinformatics 27: 582-583. doi: 10.1093/bioinformatics/btq692
2. Altfeld M, Gale M. 2015. Innate immunity against HIV-1 infection. Nature Immunology 16:554-562. doi: 10.1038/ni.3157
3. Anderson JL, Campbell EM, Wu X, Vandegraaff N, Engelman A, Hope TJ. 2006. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. Journal of Virology 80:9754-9760. doi: 10.1128/JVI.01052-06
4. Benjamin J, Ganser-Pornillos BK, Tivol WF, Sundquist WI, Jensen GJ. 2005. Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. Journal of Molecular Biology 346:577-588. doi: 10.1016/j.jmb.2004.11.064
5. Berthet-Colominas C, Monaco S, Novelli A, Sibaï G, Mallet F, Cusack S. 1999. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. The EMBO Journal 18:1124-1136. doi: 10.1093/emboj/18.5.1124
6. Bhattacharya A, Alam SL, Fricke T, Zadrozny K, Sedzicki J, Taylor AB, Demeler B, Pornillos O, Ganser-Pornillos BK, Diaz-Griffero F, Ivanov DN, Yeager M. 2014. Structural basis of HIV-1 capsid recognition by PF74 and CPSF6. Proceedings of the National Academy of Sciences of the United States of America 111:18625-18630. doi: 10.1073/pnas.1419945112
7. Bichel K, Price AJ, Schaller T, Towers GJ, Freund SM, James LC. 2013. HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358. Retrovirology 10:81. doi: 10.1186/1742-4690-10-81
8. Bieniasz PD. 2003. Restriction factors: a defense against retroviral infection. Trends in Microbiology 11:286-291. doi: 10.1016/S0966-842X(03)00123-9
9. Bieniasz PD. 2004. Intrinsic immunity: a front-line defense against viral attack. Nature Immunology 5:1109-1115. doi: 10.1038/ni1125
10. Biris N, Tomashevski A, Bhattacharya A, Diaz-Griffero F, Ivanov DN. 2013. Rhesus monkey TRIM5a SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core. Journal of Molecular Biology 425:5032-5044. doi: 10.1016/j.jmb.2013.07.025
11. Biris N, Yang Y, Taylor AB, Tomashevski A, Guo M, Hart PJ, Diaz-Griffero F, Ivanov DN. 2012. Structure of the rhesus monkey TRIM5a PRYSPRY domain, the HIV capsid recognition module. Proceedings of the National Academy of Sciences of the United States of America 109:13278-13283. doi: 10.1073/pnas.1203536109
12. Black LR, Aiken C. 2010. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro. Journal of Virology 84:6564-6569. doi: 10.1128/JVI.00210-10
13. Blair WS, Pickford C, Irving SL, Brown DG, Anderson M, Bazin R, Cao J, Ciaramella G, Isaacson J, Jackson L, Hunt R, Kjerrstrom A, Nieman JA, Patick AK, Perros M, Scott AD, Whitby K, Wu H, Butler SL. 2010. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathogens 6:e1001220. doi: 10.1371/journal.ppat.1001220
14. Braaten D, Franke EK, Luban J. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. Journal of Virology 70:3551-3560
15. Brennan G, Kozyrev Y, Hu SL. 2008. TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proceedings of the National Academy of Sciences of the United States of America 105:3569-3574. doi: 10.1073/pnas.0709511105
16. Briggs JA, Grunewald K, Glass B, Forster F, Krausslich HG, Fuller SD. 2006. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure 14:15-20. doi: 10.1016/j.str.2005.09.010
17. Briggs JA, Simon MN, Gross I, Krausslich HG, Fuller SD, Vogt VM, Johnson MC. 2004. The stoichiometry of Gag protein in HIV-1. Nature Structural & Molecular Biology 11:672-675. doi: 10.1038/nsmb785
18. Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD. 2003. Structural organization of authentic, mature HIV-1 virions and cores. The EMBO Journal 22:1707-1715. doi: 10.1093/emboj/cdg143
19. Butan C, Winkler DC, Heymann JB, Craven RC, Steven AC. 2008. RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. Journal of Molecular Biology 376:1168-1181. doi: 10.1016/j.jmb.2007.12.003
20. Byeon IJ, Meng X, Jung J, Zhao G, Yang R, Ahn J, Shi J, Concel J, Aiken C, Zhang P, Gronenborn AM. 2009. Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 139:780-790. doi: 10.1016/j.cell.2009.10.010
21. Caines ME, Bichel K, Price AJ, McEwan WA, Towers GJ, Willett BJ, Freund SM, James LC. 2012. Diverse HIV viruses are targeted by a conformationally dynamic antiviral. Nature Structural & Molecular Biology 19:411-416. doi: 10.1038/nsmb.2253
22. Campbell EM, Perez O, Anderson JL, Hope TJ. 2008. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. Journal of Cell Biology 180:549-561. doi: 10.1083/jcb.200706154
23. Campbell EM, Weingart J, Sette P, Opp S, Sastri J, O’Connor SK, Talley S, Diaz-Griffero F, Hirsch V, Bouamr F. 2016. TRIM5a-mediated ubiquitin chain conjugation Is required for inhibition of HIV-1 reverse transcription and capsid destabilization. Journal of Virology 90:1849-1857. doi: 10.1128/JVI.01948-15
24. Campbell S, Vogt VM. 1995. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. Journal of Virology 69:6487-6497.
25. Campos-Olivas R, Newman JL, Summers MF. 2000. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. Journal of Molecular Biology 296: 633-649. doi: 10.1006/jmbi.1999.3475
26. Cornilescu CC, Bouamr F, Yao X, Carter C, Tjandra N. 2001. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein. Journal of Molecular Biology 306:783-797. doi: 10.1006/jmbi.2000.4395
27. Danielson CM, Cianci GC, Hope TJ. 2012. Recruitment and dynamics of proteasome association with rhTRIM5a cytoplasmic complexes during HIV-1 infection. Traffic 13:1206-1217. doi: 10.1111/j.1600-0854.2012.01381.x
28. Di Nunzio F, Fricke T, Miccio A, Valle-Casuso JC, Perez P, Souque P, Rizzi E, Severgnini M, Mavilio F, Charneau P, Diaz-Griffero F. 2013. Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology 440:8-18. doi: 10.1016/j.virol.2013.02.008
29. Diaz-Griffero F, Kar A, Lee M, Stremlau M, Poeschla E, Sodroski J. 2007. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 369:400-410. doi: 10.1016/j.virol.2007.08.032
30. Diaz-Griffero F, Li X, Javanbakht H, Song B, Welikala S, Stremlau M, Sodroski J. 2006. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349:300-315. doi: 10.1016/j.virol.2005.12.040
31. Diaz-Griffero F, Qin XR, Hayashi F, Kigawa T, Finzi A, Sarnak Z, Lienlaf M, Yokoyama S, Sodroski J. 2009. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction. Journal of Virology 83:10737-10751. doi: 10.1128/JVI.01307-09
32. Diaz-Griffero F, Vandegraaff N, Li Y, McGee-Estrada K, Stremlau M, Welikala S, Si Z, Engelman A, Sodroski J. 2006. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 351:404-419. doi: 10.1016/j.virol.2006.03.023
33. Fitzgerald ME, Rawling DC, Vela A, Pyle AM. 2014. An evolving arsenal: viral RNA detection by RIG-I-like receptors. Current Opinion in Microbiology 20:76-81. doi: 10.1016/j.mib.2014.05.004
34. Fletcher AJ, Christensen DE, Nelson C, Tan CP, Schaller T, Lehner PJ, Sundquist WI, Towers GJ. 2015. TRIM5a requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. The EMBO Journal 34:2078-2095. doi: 10.15252/embj.201490361
35. Forshey BM, von Schwedler U, Sundquist WI, Aiken C. 2002. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. Journal of Virology 76:5667-5677. doi: 10.1128/JVI.76.11.5667-5677.2002
36. Franke EK, Luban J. 1996. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222:279-282. doi: 10.1006/viro.1996.0421
37. Franke EK, Yuan HE, Luban J. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362. doi: 10.1038/372359a0
38. Fricke T, Brandariz-Nuñez A, Wang X, Smith AB, Diaz-Griffero F. 2013. Human cytosolic extracts stabilize the HIV-1 core. Journal of Virology 87:10587-10597. doi: 10.1128/JVI.01705-13
39. Fricke T, Buffone C, Opp S, Valle-Casuso J, Diaz-Griffero F. 2014. BI-2 destabilizes HIV-1 cores during infection and Prevents Binding of CPSF6 to the HIV-1 Capsid. Retrovirology 11:120. doi: 10.1186/s12977-014-0120-x
40. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP. 1996. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285-1294. doi: 10.1016/S0092-8674(00)81823-1
41. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. 1999. Assembly and analysis of conical models for the HIV-1 core. Science 283:80-83. doi: 10.1126/science.283.5398.80
42. Ganser-Pornillos BK, Chandrasekaran V, Pornillos O, Sodroski JG, Sundquist WI, Yeager M. 2011. Hexagonal assembly of a restricting TRIM5alpha protein. Proceedings of the National Academy of Sciences of the United States of America 108:534-539. doi: 10.1073/pnas.1013426108
43. Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI. 2004. Assembly properties of the human immunodeficiency virus type 1 CA protein. Journal of Virology 78:2545-2552. doi: 10.1128/JVI.78.5.2545-2552.2004
44. Ganser-Pornillos BK, Yeager M, Pornillos O. 2012. Assembly and architecture of HIV. Advances in Experimental Medicine and Biology 726:441-465. doi: 10.1007/978-1-4614-0980-9_20
45. Goldstone DC, Walker PA, Calder LJ, Coombs PJ, Kirkpatrick J, Ball NJ, Hilditch L, Yap MW, Rosenthal PB, Stoye JP, Taylor IA. 2014. Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice. Proceedings of the National Academy of Sciences of the United States of America 111:9609-9614. doi: 10.1073/pnas.1402448111
46. Gres AT, Kirby KA, KewalRamani VN, Tanner JJ, Pornillos O, Sarafianos SG. 2015. STRUCTURAL VIROLOGY capsid protein reveal conformational variability. Science 349:99-103. doi: 10.1126/science.aaa5936
47. Harris RS, Hultquist JF, Evans DT. 2012. The restriction factors of human immunodeficiency virus. The Journal of Biological Chemistry 287:40875-40883. doi: 10.1074/jbc.R112.416925
48. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD, Towers GJ. 2003. Restriction of multiple divergent retroviruses by Lv1 and Ref1. The EMBO Journal 22:385-394. doi: 10.1093/emboj/cdg042
49. Hatziioannou T, Cowan S, Von Schwedler UK, Sundquist WI, Bieniasz PD. 2004. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. Journal of Virology 78:6005-6012. doi: 10.1128/JVI.78.11.6005-6012.2004
50. Heuser J. 1980. Three-dimensional visualization of coated vesicle formation in fibroblasts. The Journal of Cell Biology 84:560-583. doi: 10.1083/jcb.84.3.560
51. Heymann JB, Butan C, Winkler DC, Craven RC, Steven AC. 2008. Irregular and Semi-Regular Polyhedral Models for Rous Sarcoma Virus Cores. Computational and Mathematical Methods in Medicine 9:197-210. doi: 10.1080/17486700802168106
52. Imam S, Talley S, Nelson RS, Dharan A, O’Connor C, Hope TJ, Campbell EM. 2016. TRIM5a Degradation via Autophagy Is Not Required for Retroviral Restriction. Journal of Virology 90:3400-3410. doi: 10.1128/JVI.03033-15
53. Javanbakht H, Diaz-Griffero F, Stremlau M, Si Z, Sodroski J. 2005. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. The Journal of Biological Chemistry 280: 26933-26940. doi: 10.1074/jbc.M502145200
54. Jin Z, Jin L, Peterson DL, Lawson CL. 1999. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. Journal of Molecular Biology 286:83-93. doi: 10.1006/jmbi.1998.2443
55. Kar AK, Diaz-Griffero F, Li Y, Li X, Sodroski J. 2008. Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein. Journal of Virology 82:11669-11681. doi: 10.1128/JVI.01559-08
56. Khorasanizadeh S, Campos-Olivas R, Summers MF. 1999. Solution structure of the capsid protein from the human T-cell leukemia virus type-I. Journal of Molecular Biology 291:491-505. doi: 10.1006/jmbi.1999.2986
57. Kingston RL, Fitzon-Ostendorp T, Eisenmesser EZ, Schatz GW, Vogt VM, Post CB, Rossmann MG. 2000. Structure and self-association of the Rous sarcoma virus capsid protein. Structure 8:617-628. doi: 10.1016/S0969-2126(00)00148-9
58. Kotov A, Zhou J, Flicker P, Aiken C. 1999. Association of Nef with the human immunodeficiency virus type 1 core. Journal of Virology 73:8824-8830.
59. Kovalskyy DB, Ivanov DN. 2014. Recognition of the HIV capsid by the TRIM5a restriction factor is mediated by a subset of pre-existing conformations of the TRIM5a SPRY domain. Biochemistry 53:1466-1476. doi: 10.1021/bi4014962
60. Kremer JR, Mastronarde DN, McIntosh JR. 1996. Computer visualization of three-dimensional image data using IMOD. Journal of Structural Biology 116:71-76. doi: 10.1006/jsbi.1996.0013
61. Kutluay SB, Perez-Caballero D, Bieniasz PD. 2013. Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathogens 9:e1003214. doi: 10.1371/journal.ppat.1003214
62. Lamorte L, Titolo S, Lemke CT, Goudreau N, Mercier J-F, Wardrop E, Shah VB, von Schwedler UK, Langelier C, Banik SSR, Aiken C, Sundquist WI, Mason SW. 2013. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes. Antimicrobial Agents and Chemotherapy 57:4622-4631. doi: 10.1128/AAC.00985-13
63. Langelier CR, Sandrin V, Eckert DM, Christensen DE, Chandrasekaran V, Alam SL, Aiken C, Olsen JC, Kar AK, Sodroski JG, Sundquist WI. 2008. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. Journal of Virology 82:11682-11694. doi: 10.1128/JVI.01562-08
64. Lanman J, Lam TT, Emmett MR, Marshall AG, Sakalian M, Prevelige PE. 2004. Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nature Structural & Molecular Biology 11:676-677. doi: 10.1038/nsmb790
65. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, et al. 2010. Flexible use of nuclear import pathways by HIV-1. Cell Host & Microbe 7:221-233. doi: 10.1016/j.chom.2010.02.007
66. Li S, Hill CP, Sundquist WI, Finch JT. 2000. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409-413. doi: 10.1038/35030177
67. Li X, Kim J, Song B, Finzi A, Pacheco B, Sodroski J. 2013. Virus-specific effects of TRIM5a(rh) RING domain functions on restriction of retroviruses. Journal of Virology 87:7234-7245. doi: 10.1128/JVI.00620-13
68. Li X, Sodroski J. 2008. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. Journal of Virology 82:11495-11502. doi: 10.1128/JVI.01548-08
69. Li Y, Li X, Stremlau M, Lee M, Sodroski J. 2006. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. Journal of Virology 80:6738-6744. doi: 10.1128/JVI.00270-06
70. Li Y, Wu H, Wu W, Zhuo W, Liu W, Zhang Y, Cheng M, Chen YG, Gao N, Yu H, Wang L, Li W, Yang M. 2014. Structural insights into the TRIM family of ubiquitin E3 ligases. Cell Research 24:762-765. doi: 10.1038/cr.2014.46
71. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078. doi: 10.1016/0092-8674(93)90637-6
72. Lukic Z, Hausmann S, Sebastian S, Rucci J, Sastri J, Robia SL, Luban J, Campbell EM. 2011. TRIM5a associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 8:93. doi: 10.1186/1742-4690-8-93
73. Mandell MA, Jain A, Arko-Mensah J, Chauhan S, Kimura T, Dinkins C, Silvestri G, Munch J, Kirchhoff F, Simonsen A, Wei Y, Levine B, Johansen T, Deretic V. 2014a. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Developmental Cell 30:394-409. doi: 10.1016/j.devcel.2014.06.013
74. Mandell MA, Kimura T, Jain A, Johansen T, Deretic V. 2014b. TRIM proteins regulate autophagy: TRIM5 is a selective autophagy receptor mediating HIV-1 restriction. Autophagy 10:2387-2388. doi: 10.4161/15548627.2014.984278
75. Matreyek KA, Yucel SS, Li X, Engelman A. 2013. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathogens 9: e1003693. doi: 10.1371/journal.ppat.1003693
76. Meehan AM, Saenz DT, Guevera R, Morrison JH, Peretz M, Fadel HJ, Hamada M, van Deursen J, Poeschla EM. 2014. A cyclophilin homology domain-independent role for Nup358 in HIV-1 infection. PLoS Pathogens 10: e1003969. doi: 10.1371/journal.ppat.1003969
77. Meroni G, Diez-Roux G. 2005. TRIM/RBCC, a novel class of’single protein RING finger’ E3 ubiquitin ligases. BioEssays 27:1147-1157. doi: 10.1002/bies.20304
78. Momany C, Kovari LC, Prongay AJ, Keller W, Gitti RK, Lee BM, Gorbalenya AE, Tong L, McClure J, Ehrlich LS, Summers MF, Carter C, Rossmann MG. 1996. Crystal structure of dimeric HIV-1 capsid protein. Nature Structural Biology 3:763-770. doi: 10.1038/nsb0996-763
79. Monroe EB, Kang S, Kyere SK, Li R, Prevelige PE. 2010. Hydrogen/deuterium exchange analysis of HIV-1 capsid assembly and maturation. Structure 18:1483-1491. doi: 10.1016/j.str.2010.08.016
80. Mortuza GB, Dodding MP, Goldstone DC, Haire LF, Stoye JP, Taylor IA. 2008. Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, gag assembly and core formation. Journal of Molecular Biology 376:1493-1508. doi: 10.1016/j.jmb.2007.12.043
81. Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, Taylor IA. 2004. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431:481-485. doi: 10.1038/nature02915
82. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proceedings of the National Academy of Sciences of the United States of America 93:11382-11388. doi: 10.1073/pnas.93.21.11382
83. Neil S, Bieniasz P. 2009. Human immunodeficiency virus, restriction factors, and interferon. Journal of Interferon & Cytokine Research 29:569-580. doi: 10.1089/jir.2009.0077
84. Newman RM, Hall L, Kirmaier A, Pozzi LA, Pery E, Farzan M, O’Neil SP, Johnson W. 2008. Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathogens 4:e1000003. doi: 10.1371/journal.ppat.1000003
85. Nicastro D, Schwartz C, Pierson J, Gaudette R, Porter ME, McIntosh JR. 2006. The molecular architecture of axonemes revealed by cryoelectron tomography. Science 313:944-948. doi: 10.1126/science.1128618
86. Nisole S, Lynch C, Stoye JP, Yap MW. 2004. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proceedings of the National Academy of Sciences of the United States of America 101: 13324-13328. doi: 10.1073/pnas.0404640101
87. Obal G, Trajtenberg F, Carrión F, Tomé L, Larrieux N, Zhang X, Pritsch O, Buschiazzo A. 2015. Conformational plasticity of a native retroviral capsid revealed by x-ray crystallography. Science 349:95-98. doi: 10.1126/science.aaa5182
88. Ohkura S, Yap MW, Sheldon T, Stoye JP. 2006. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. Journal of Virology 80:8554-8565. doi: 10.1128/JVI.00688-06
89. Perez-Caballero D, Hatziioannou T, Yang A, Cowan S, Bieniasz PD. 2005. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. Journal of Virology 79:8969-8978. doi: 10.1128/JVI.79.14.8969-8978.2005
90. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, Grutter MG, Luban J. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365. doi: 10.1038/nature09976
91. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry 25:1605-1612. doi: 10.1002/jcc.20084
92. Pornillos O, Ganser-Pornillos BK, Banumathi S, Hua Y, Yeager M. 2010. Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus. Journal of Molecular Biology 401:985-995. doi: 10.1016/j.jmb.2010.06.042
93. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M. 2009. X-ray structures of the hexameric building block of the HIV capsid. Cell 137:1282-1292. doi: 10.1016/j.cell.2009.04.063
94. Pornillos O, Ganser-Pornillos BK, Yeager M. 2011. Atomic-level modelling of the HIV capsid. Nature 469:424-427. doi: 10.1038/nature09640
95. Price AJ, Jacques DA, McEwan WA, Fletcher AJ, Essig S, Chin JW, Halambage UD, Aiken C, James LC. 2014. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly. PLoS Pathogens 10:e1004459. doi: 10.1371/journal.ppat.1004459
96. Price AJ, Marzetta F, Lammers M, Ylinen LM, Schaller T, Wilson SJ, Towers GJ, James LC. 2009. Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nature Structural & Molecular Biology 16:1036-1042. doi: 10.1038/nsmb.1667
97. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A. 2001. The tripartite motif family identifies cell compartments. The EMBO Journal 20:2140-2151. doi: 10.1093/emboj/20.9.2140
98. Roa A, Hayashi F, Yang Y, Lienlaf M, Zhou J, Shi J, Watanabe S, Kigawa T, Yokoyama S, Aiken C, Diaz-Griffero F. 2012. RING domain mutations uncouple TRIM5a restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. Journal of Virology 86:1717-1727. doi: 10.1128/JVI.05811-11
99. Rold CJ, Aiken C. 2008. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathogens 4: e1000074. doi: 10.1371/journal.ppat.1000074
100. Rustagi A, Gale M. 2014. Innate antiviral immune signaling, viral evasion and modulation by HIV-1. Journal of Molecular Biology 426:1161-1177. doi: 10.1016/j.jmb.2013.12.003
101. Sainsbury S, Ren J, Saunders NJ, Stuart DI, Owens RJ. 2008. Crystallization and preliminary X-ray analysis of CrgA, a LysR-type transcriptional regulator from pathogenic Neisseria meningitidis MC58. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications 64:797-801. doi: 10.1107/S1744309108024068
102. Salmon P, Oberholzer J, Occhiodoro T, Morel P, Lou J, Trono D. 2000. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Molecular Therapy 2:404-414. doi: 10.1006/mthe.2000.0141
103. Sanchez JG, Okreglicka K, Chandrasekaran V, Welker JM, Sundquist WI, Pornillos O. 2014. The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proceedings of the National Academy of Sciences of the United States of America 111:2494-2499. doi: 10.1073/pnas.1318962111
104. Sandrin V, Boson B, Salmon P, Gay W, Nègre D, Le Grand R, Trono D, Cosset FL. 2002. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100:823-832. doi: 10.1182/blood-2001-11-0042
105. Sayah DM, Sokolskaja E, Berthoux L, Luban J. 2004. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569-573. doi: 10.1038/nature02777
106. Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hué S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ. 2011. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathogens 7: e1002439. doi: 10.1371/journal.ppat.1002439
107. Sebastian S, Luban J. 2005. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2 40. doi: 10.1186/1742-4690-2-40
108. Shi J, Friedman DB, Aiken C. 2013. Retrovirus restriction by TRIM5 proteins requires recognition of only a small fraction of viral capsid subunits. Journal of Virology 87:9271-9278. doi: 10.1128/JVI.00713-13
109. Song B, Gold B, O’Huigin C, Javanbakht H, Li X, Stremlau M, Winkler C, Dean M, Sodroski J. 2005. The B30.2 (SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. Journal of Virology 79:6111-6121. doi: 10.1128/JVI.79.10.6111-6121.2005
110. Song B, Javanbakht H, Perron M, Park DH, Stremlau M, Sodroski J. 2005. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. Journal of Virology 79:3930-3937. doi: 10.1128/JVI.79.7.3930-3937.2005
111. Sparrer KM, Gack MU. 2015. Intracellular detection of viral nucleic acids. Current Opinion in Microbiology 26:1-9. doi: 10.1016/j.mib.2015.03.001
112. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. doi: 10.1038/nature02343
113. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proceedings of the National Academy of Sciences of the United States of America 103:5514-5519. doi: 10.1073/pnas.0509996103
114. Stremlau M, Perron M, Welikala S, Sodroski J. 2005. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. Journal of Virology 79:3139-3145. doi: 10.1128/JVI.79.5.3139-3145.2005
115. Studier FW. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expression and Purification 41:207-234. doi: 10.1016/j.pep.2005.01.016
116. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, Gottlinger HG. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363-365. doi: 10.1038/372363a0
117. van Montfoort N, Olagnier D, Hiscott J. 2014. Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectors. Cytokine Growth Factor Reviews 25:657-668. doi: 10.1016/j.cytogfr.2014.08.006
118. Virgen CA, Kratovac Z, Bieniasz PD, Hatziioannou T. 2008. Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proceedings of the National Academy of Sciences of the United States of America 105:3563-3568. doi: 10.1073/pnas.0709258105
119. von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, Sundquist WI. 1998. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. The EMBO Journal 17: 1555-1568. doi: 10.1093/emboj/17.6.1555
120. Vuillard L, Braun-Breton C, Rabilloud T. 1995. Non-detergent sulphobetaines: a new class of mild solubilization agents for protein purification. The Biochemical Journal 305:337-343. doi: 10.1042/bj3050337
121. Wagner JM, Roganowicz MD, Skorupka K, Alam SL, Christensen DE, Doss GL, Wan Y, Frank GA, Ganser-Pornillos BK, Sundquist WI, Pornillos O. 2016. Mechanism of B-box 2 domain-mediated higher-order assembly of the retroviral restriction factor TRIM5a. eLife 5:e16309. doi: 10.7554/eLife.16309
122. Wear MA, Patterson A, Malone K, Dunsmore C, Turner NJ, Walkinshaw MD. 2005. A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A. Analytical Biochemistry 345:214-226. doi: 10.1016/j.ab.2005.06.037
123. Weinert C, Morger D, Djekic A, Grutter MG, Mittl PR. 2015. Crystal structure of TRIM20 C-terminal coiled-coil/ B30.2 fragment: implications for the recognition of higher order oligomers. Scientific Reports 5:10819. doi: 10.1038/srep10819
124. Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich HG. 2000. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. Journal of Virology 74:1168-1177. doi: 10.1128/JVI.74.3.1168-1177.2000
125. Wilson SJ, Webb BL, Maplanka C, Newman RM, Verschoor EJ, Heeney JL, Towers GJ. 2008. Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. Journal of Virology 82:7243-7247. doi: 10.1128/JVI.00307-08
126. Wu X, Anderson JL, Campbell EM, Joseph AM, Hope TJ. 2006. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proceedings of the National Academy of Sciences of the United States of America 103:7465-7470. doi: 10.1073/pnas.0510483103
127. Yamauchi K, Wada K, Tanji K, Tanaka M, Kamitani T. 2008. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. The FEBS Journal 275:1540-1555. doi: 10.1111/j.1742-4658.2008.06313.x
128. Yang H, Ji X, Zhao G, Ning J, Zhao Q, Aiken C, Gronenborn AM, Zhang P, Xiong Y. 2012. Structural insight into HIV-1 capsid recognition by rhesus TRIM5a. Proceedings of the National Academy of Sciences of the United States of America 109:18372-18377. doi: 10.1073/pnas.1210903109
129. Yap MW, Nisole S, Stoye JP. 2005. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Current Biology 15:73-78. doi: 10.1016/j.cub.2004.12.042
130. Yee JK, Friedmann T, Burns JC. 1994. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods in Cell Biology 43 Pt A:99-112. doi: 10.1016/s0091-679x(08)60600-7
131. Ylinen LM, Price AJ, Rasaiyaah J, Hué S, Rose NJ, Marzetta F, James LC, Towers GJ. 2010. Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity. PLoS Pathogens 6:e1001062. doi: 10.1371/journal.ppat.1001062
132. Yoo JS, Kato H, Fujita T. 2014. Sensing viral invasion by RIG-I like receptors. Current Opinion in Microbiology 20: 131-138. doi: 10.1016/j.mib.2014.05.011
133. Yoo S, Myszka DG, Yeh C, McMurray M, Hill CP, Sundquist WI. 1997. Molecular recognition in the HIV-1 capsid/ cyclophilin A complex. Journal of Molecular Biology 269:780-795. doi: 10.1006/jmbi.1997.1051
134. Yu Z, Dobro MJ, Woodward CL, Levandovsky A, Danielson CM, Sandrin V, Shi J, Aiken C, Zandi R, Hope TJ, Jensen GJ. 2013. Unclosed HIV-1 capsids suggest a curled sheet model of assembly. Journal of Molecular Biology 425:112-123. doi: 10.1016/j.jmb.2012.10.006
135. Yudina Z, Roa A, Johnson R, Biris N, de Souza Aranha Vieira DA, Tsiperson V, Reszka N, Taylor AB, Hart PJ, Demeler B, Diaz-Griffero F, Ivanov DN. 2015. RING Dimerization Links Higher-Order Assembly of TRIM5a to Synthesis of K63-Linked Polyubiquitin. Cell Reports 12:788-797. doi: 10.1016/j.celrep.2015.06.072
136. Zhang W, Cao S, Martin JL, Mueller JD, Mansky LM. 2015. Morphology and ultrastructure of retrovirus particles. AIMS Biophysics 2:343-369. doi: 10.3934/biophy.2015.3.343
137. Zhao G, Ke D, Vu T, Ahn J, Shah VB, Yang R, Aiken C, Charlton LM, Gronenborn AM, Zhang P. 2011. Rhesus TRIM5a disrupts the HIV-1 capsid at the inter-hexamer interfaces. PLoS Pathogens 7:e1002009. doi: 10.1371/journal.ppat.1002009
138. Zhao G, Perilla JR, Yufenyuy EL, Meng X, Chen B, Ning J, Ahn J, Gronenborn AM, Schulten K, Aiken C, Zhang P. 2013. Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics. Nature 497:643-646. doi: 10.1038/nature12162
139. Zheng SQ, Keszthelyi B, Branlund E, Lyle JM, Braunfeld MB, Sedat JW, Agard DA. 2007. UCSF tomography: an integrated software suite for real-time electron microscopic tomographic data collection, alignment, and reconstruction. Journal of Structural Biology 157:138-147. doi: 10.1016/j.jsb.2006.06.005
140. Zlotnick A, Stahl SJ, Wingfield PT, Conway JF, Cheng N, Steven AC. 1998. Shared motifs of the capsid proteins of hepadnaviruses and retroviruses suggest a common evolutionary origin. FEBS Letters 431:301-304. doi: 10.1016/S0014-5793(98)00755-8